— Know what they know.
Not Investment Advice

ARDX NASDAQ

Ardelyx, Inc.
1W: -1.7% 1M: +5.5% 3M: +10.8% YTD: +3.2% 1Y: +51.9% 3Y: +42.4% 5Y: +273.5%
$6.11
-0.24 (-3.78%)
 
Weekly Expected Move ±7.7%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 53 · $1.5B mcap · 236M float · 1.60% daily turnover · Short 48% of daily vol

📊 Key Metrics

TTM
$428M
Revenue
+18.2% YoY
$-58M
Net Income
-8.0% YoY
$-37M
Free Cash Flow
+23.0% YoY
94.9%
Gross Margin
-34.7%
Op. Margin
-39.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-34.1%
ROA-12.4%
ROIC-26.0%

Valuation

P/E-25.9
P/B10.1
EV/EBITDA-44.5

Leverage

Debt/Equity1.27
Current Ratio4.31
Interest Cov.-1.3x

Quality Scores

Piotroski F4/9
Altman Z1.32
Beneish M-2.36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms